DMARGE MAGAZINE: Psychedelics Tycoon JJ Wilson On Psilocybin, MDMA & Australia’s Mental Health Renaissance
Click on Image to Read Full Interview.
We hope you find what you’re looking for. You can email us if you need additional help.
Click on Image to Read Full Interview.
Click on the link for full story. TGA OKs mushrooming growth in psychedelic therapies (thenewdaily.com.au)
Click on the link for full story. Companies sense opportunity in psychedelic legalisation | The Canberra Times | Canberra, ACT
Click on the link for full story. Psilocybin Is Now Legal In Australia: Here’s Everything You Need To Know – DMARGE
In something of a bolt from the blue, Mattha Busby of The Intercept shared the groundbreaking news from Washington D.C. on Tuesday, July 26, that the Biden Administration is preparing for the reality of FDA approval for psychedelic-assisted therapies involving
VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (“Optimi” or the “Company”), a homegrown, Canadian company cultivating and synthesizing high quality psychedelics and natural functional and psilocybin mushroom strains for transformational human experiences, is pleased to
Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. The first involves Halucenex Life Sciences Inc. owned by Australian Creso Pharma (CPH). Halucenex’s mission involves researching novel psychedelic compounds,
By Taya Fast  Global News Magic mushrooms are now growing in Princeton, B.C., as a new mushroom research and development facility opened on Friday. Optimi Health Corp. is a Canadian-based company that grows psilocybin-producing mushrooms and functional mushrooms for clinical trials, drug companies, and
By Azuka Onwuka Optimi Health Corp (OPTI) has signed a supply agreement with Filament Health, a clinical-stage natural psychedelic drug development company. Filament has engaged Optimi to supply psilocybin mushrooms cultivated in Optimi’s recently inaugurated 20,000 square foot
Regulator Filings
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th